desde Redalyc
{{t.titulosHerramientas.nube}}
{{t.titulosHerramientas.numeros}}
X
{{t.formats.viewer}}
PDF
HTML
{{t.formats.mobile}}
ePUB
XML JATS
{{t.titulosSecciones.citas}}
{{t.titulosSecciones.autorias}}
{{t.titulosSecciones.descargas}}
{{t.titulosSecciones.revision}}
Abstract: Objective: To describe the current situation regarding the specialized pharmaceutical service provision in nursing homes in Spain, from a health-care perspective reflecting activity, care and services provided.Method: Observational, cross-sectional, multice
en es
Abstract: Objective: To describe a risk-sharing program’s implementation and results on enzyme replacement therapy for lysosomal diseases.Method: The program was designed and implemented in a referral hospital for congenital metabolic diseases. The conclusion of agre
en es
Abstract: Objective: Intrapleural administration of fibrinolytics and dornase alfa has been shown in randomized studies to be able to reduce both the need for surgical debridement of empyema and the average hospital stay. However, its application in clinical practice
en es
Abstract: Nowadays, scientific communication is enriched by the use of new ways of storing, publishing and disseminating research findings. Said new ways of scientific communication are known as the so-called academic profile platforms, which include Scopus author ID,
en es
Abstract: The development and commercialization of cell therapy drugs with chimeric antigen receptor T cells (CAR-T) represent a new challenge for Spain’s hospital pharmacy. The aim of this article is to review the key aspects of these medicines and to describe the onc
en es
|
|
||
|---|---|---|
|
|
||
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} |  |
|
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} | |
|
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} | |
|
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} | |
|
| {{criterio.prioridadCriterio}}. {{criterio.observaciones}} | |
|